T he gap junctions are clusters of transmembrane channels that mediate direct communication between the cytoplasmic compartments of adjacent cells. These channels, permeable to ions and small molecules (Ͻ900 Da), including second messengers, are the structural components responsible for intercellular electrical and metabolic coupling. The proteins that form these channels are encoded by a multigene family, the connexin (Cx) family. Each Cx forms channels that have unique properties of conductance and permeability. The structure and the oligomerization of Cxs into gap junction channels, and the properties and the functions of these channels, have recently been reviewed. [1] [2] [3] [4] [5] [6] [7] [8] In excitable tissues, such as the myocardial tissues, the gap junction channels are the sites of electrical coupling between myocytes and are responsible for the coordinated propagation of electrical activity that triggers the sequential contraction of the cardiac chambers. 9, 10 Understanding this conduction phenomenon requires the identification of Cx genes expressed in the myocytes and a detailed investigation of the spatial distribution of Cxs in the heart. It has thus been demonstrated that 3 Cxs are associated with the myocytes in the mammalian heart, Cx43, Cx40, and Cx45, and that each Cx is expressed with its own unique characteristics (for review, see Reference 10).
Cx43 is the major gap junction protein in the adult mammalian heart. It is abundantly expressed in the different myocardial tissues (ventricles, atria, septa, His bundle, etc), but its putative presence in some specific regions such as the sinoatrial and atrioventricular nodes is still a subject of controversy. 11, 12 In mouse, Cx43 protein was detected as early as 9.5 days postcoitum (dpc) in the primitive ventricle and then at 12.5 dpc in the atria. 13 From this stage its abundance steadily increases up to the adult stage. 14 Analysis of the heart of mice homozygous or heterozygous for a Cx43 null mutation has demonstrated that this Cx is involved in the propagation of the electrical activity, mainly in the ventricles, but that, in addition, and unexpectedly, Cx43 is essential for normal myocardial development. [15] [16] [17] [18] The second Cx expressed in the myocytes is Cx40. A characteristic that emerges from the numerous investigations on Cx40 in adult mammalian heart is its expression in the atrial and conduction tissues associated with its nonexpression in the working ventricular tissue. 10, 12, 19 This distribution pattern of Cx40 in adult heart is the consequence of strong spatiotemporal downregulation that occurs during fetal life. 13, 20 The abundance of Cx40 in the ventricular conduction system has been interpreted as evidence of the specific implication of this Cx in the fast-conduction phenomenon. Electrophysiological analysis of the heart of mice homozygous for a Cx40 null mutation has confirmed this interpretation and, in addition, demonstrated that the absence of Cx40 leads to cardiac rhythm defects and conduction blocks. 21, 22 Of the 3 Cxs associated with cardiomyocytes, Cx45 is probably the least known. Human Cx45 channels, for example, have 2 major characteristics, as follows: (1) their unitary conductance (␥ j ) is low (15 to 30 pS) [23] [24] [25] compared with the unitary conductance of other gap junctional channels, and (2) their macroscopic conductance (g j ) is strongly voltage sensitive, 10, 24 in contrast to the weak voltage dependence of Cx43 and Cx40 channels. 10, 24 This latter property implies that a slight difference in membrane potential (equivalent to a transjunctional voltage) between myocytes, such as may occur during the normal cardiac cycle, can potentially close Cx45 channels. Cx45 gene transcript was detected in low abundance in adult and embryonic mammalian hearts. 20,26 -29 Cx45 protein, which is phosphorylated, 30 -32 was reported to have a widespread distribution in dog and human heart and to be a component of the gap junctions of all types of myocytes (working, conductive, and nodal myocytes). 27, 28, [33] [34] [35] [36] This Cx was also shown to be expressed in quantities that are far from negligible in cultured neonatal rat heart myocytes [31] [32] [33] [34] [35] [36] [37] and also in rabbit atrial and ventricular myocardium. 38 In marked contrast with these results, recent investigations have demonstrated that Cx45 was very weakly expressed in adult and embryonic mouse and rat heart and had a distribution pattern restricted to the conduction system. 29, 39 In this study, we report the expression of Cx45 gene products in mouse heart from early stages of cardiac morphogenesis (8.5 dpc) to the adult stage and demonstrate that Cx45, distributed in all cardiac compartments at early stages, is subject to spatiotemporal regulation that restricts both its expression level and distribution in adult heart.
Materials and Methods

Biological Material
The human SKHep1 and HeLa cells and the rat UMR 106 cells (wild types) were cultured as described previously. 24, 40, 41 Ovaries and hearts were dissected from adult mice. Hearts and forelimb buds were collected from mouse embryos at different developmental stages. The developmental stage of these embryos was checked by determining the number of somites and analyzing the morphology of the heart. 42 For the reverse transcriptase (RT)-polymerase chain reaction (PCR) experiments, the hearts from mouse embryos and newborn and adult mice were collected under sterile conditions, and great care was taken to ensure that only the heart was removed. 13 RNA was extracted from hearts using the guanidinium thiocyanate-phenolchloroform method. 43 pBluescripts containing either the complete coding region of the mouse Cx45 (pF9-7 and pIVT) 26 or the 3Ј end of the rat sarcoplasmic/endoplasmic reticulum Ca 2ϩ -ATPase 2 (SERCA 2; pRH39) 44, 45 were propagated in Escherichia coli XL1 Blue and purified according to standard protocols.
Identification of Transcripts by RT-PCR
RT-PCR Experiments
RNA samples (2 g) extracted from mouse hearts at different developmental stages (from 8.5 dpc to the adult stage) were reverse transcribed using the oligo-dT primers included in the First Strand cDNA Synthesis Kit (Pharmacia Biotech). The PCR experiments were carried out as described 13 using the murine sequences of GAPDH, Cx45, and desmin genes 26, 46, 47 (Table) . For the 8.5-dpc samples, products amplified with primers specific for Cx45 were subjected to a second step of PCR using internal primers (Table; nested PCR). All of the RNA samples were tested for DNA contamination with experiments carried out in the absence of RT. Blank reactions were also performed without RNA.
Analysis of Amplification Products
To determine that the DNA fragments amplified with the primers specific for Cx45 were those predicted, the fragments were digested with endonucleases. The analysis of the mouse Cx45 sequence indicates that the PCR-amplified 915-bp fragment (Table) has to contain unique restriction sites for BglII (ϩ65) and BamHI (ϩ407). 26 The 915-bp fragment was digested with these enzymes, and the digestion products were analyzed with 1% agarose gel stained with ethidium bromide. Alternatively, the 915-bp fragment was also amplified by nested PCR as described above for the 8.5-dpc samples.
In Situ Hybridization
Whole-Mount In Situ Hybridization
The whole-mount in situ hybridizations carried out with mouse embryos ranging from 8.0 to 12.5 dpc were performed as previously described in detail. 13 Control experiments were carried out with anti-digoxigenin antibodies on nonhybridized embryos and embryos treated with the sense probe.
pF9-7 was modified by excision of the 1.6-kb fragment included between the 2 XbaI restriction sites localized in the polylinker and the Cx45 coding region (ϩ667). The single-stranded antisense and sense RNA probes were synthesized from the modified plasmid in the presence of UTP-digoxigenin (Boehringer Mannheim) according to the manufacturer's instructions. The 0.95-kb Cx45 antisense probe was synthesized with T7 RNA-polymerase from the XbaI-linearized plasmid; the sense probe was synthesized with T3 RNA-polymerase from the XhoI-linearized plasmid. The probes matched 521 bp of the C-terminal coding region of the mouse Cx45 gene plus 429 bp of the 3Ј-untranslated region. 26 
In Situ Hybridization on Sections
In situ hybridizations were carried out on serial sections of 14-, 16-, and 18-dpc embryos as previously described. 45 The hybridizations were performed with 30 pg of 35 S-labeled antisense RNA (16 to 18 hours; 54°C) in 6 to 10 L of hybridization mixture per section (50% formamide, 10% dextransulfate, 2ϫ Denhardt's solution, 0.1% Triton X-100, and 200 ng/L of herring sperm DNA, and [in mmol/ L] NaCl 300, sodium citrate 30, and DTT 10; pH 7.4). The specific activity of the cRNA was 1.5ϫ10 9 cpm/g. 
Preparation of Antibodies Directed to Residues 285 to 298 of Cx45
The peptides, (Y)SAPPGYNIAVKPDQ (corresponding to amino acids 285 to 298 of mouse Cx45), 26 (Y)SAPPGY, and NIAVKPDQ, were synthesized in solid phase. The first peptide, (Y)SAPPGYNI-AVKPDQ, which is conserved in mouse, chick, dog, and human Cx45, 26, 33, 35, 48 was conjugated to BSA using bis-diazobenzidine as a cross-linker. The protocols used for the immunization of rabbits with the BSA-peptide complex, the affinity purification of antibodies from immune sera, and the ELISAs have been described previously. 13, 49 The antibodies directed to residues 285 to 298 of the mouse Cx45 will be referred to as antibodies 285/298. The preimmune sera were subjected to the same purification steps as the immune sera. The collected fractions, used in control experiments, will be referred to as preimmune fractions.
Immunoblotting Analysis
The samples were homogenized in a solubilization buffer (150 mmol/L NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, and 50 mmol/L Tris-HCl, pH 7.4) supplemented with inhibitors (2.5 mmol/L pretreated orthovanadate, 2 mmol/L phenylarsine oxide, and 125 mol/L phenylmethylsulfonyl fluoride) and processed as described. 13 Alternatively, the samples were frozen in liquid nitrogen; freeze dried; solubilized for 30 minutes in a solution containing 62.5 mmol/L Tris-HCl (pH 6.8), 20% SDS, 5% mercaptoethanol, 10 mmol/L EDTA, and 5% glycerol, supplemented with the inhibitors described above; and then centrifuged for 30 minutes at 13 000g at 4°C. The supernatants containing the solubilized material according to both protocols were recovered, and the total amount of protein was quantified using a bicinchoninic acid assay (Sigma Aldrich Chimie). Solubilized proteins were separated by SDS-PAGE and then electrotransferred onto Nitroscreen membranes (Amersham) according to standard procedures. The transferred proteins were probed for the presence of Cx43 or Cx45 using rabbit anti-Cx43 antibodies (0.2 to 0.5 g/mL) 50 or antibodies 285/298 (2.5 to 5 g/mL) (see above), as described. 13 The membranes were then incubated with biotinconjugated F(abЈ) 2 fragments from goat anti-rabbit IgGs (Immunotech) (dilution 1:1500; 1 hour at room temperature) and then with peroxidase-conjugated streptavidin (Immunotech) (dilution 1:2500; 1 hour at room temperature). Peroxidase was detected with a chemiluminescence detection reagent kit (Boehringer Mannheim) according to the manufacturer's instructions. The chemiluminescence reaction was visualized on Hyperfilm-MP (Amersham). After exposure, some membranes were washed for 90 seconds with Tris-buffered saline containing 0.2% Tween 20 before being reexposed. The specificity of immunodetections was checked by (1) the omission of the primary antibodies (antibodies 285/298), (2) the replacement of the primary antibodies by a preimmune fraction, and (3) the replacement of the primary antibodies by a solution of primary antibodies preincubated overnight at 4°C with the immunogenic peptide (100 g/mL).
Immunofluorescence Analyses
Antibodies
The anti-desmin mouse monoclonal antibody (clone DE-U-10, Sigma Aldrich Chimie), diluted to 1:50, was used as marker of myocytes. 51 The anti-Cx43 mouse monoclonal antibody (Zymed Laboratories, Inc), the rabbit polyclonal anti-Cx40 antibodies, 13 and the rabbit polyclonal antibodies 285/298 were used at 2, 3, and 3 to 10 g/mL, respectively. 13 The antibodies, including the secondary antibodies (see below), were diluted in a saturation solution containing 1% (wt/vol) BSA and 0.05% (vol/vol) saponin.
Single-Labeling Experiments
SKHep1, HeLa, and UMR 106 cells were cultured on gelatin-coated coverslips, fixed, and permeabilized according to a previously described procedure. 13 The cells were incubated overnight at 4°C with antibodies 285/298, washed with PBS, and incubated for 1 hour at room temperature with TRITC-labeled goat anti-rabbit IgGs (Sigma Aldrich Chimie; dilution, 1:50) and then processed as described. 13 The different organs that were collected were embedded in Tissue-Tek OCT compound (Miles Laboratories), after fixation (15 minutes in 2% formaldehyde solution in PBS) or without fixation, and then frozen in isopentane precooled at Ϫ30°C. Frozen sections, mounted on gelatin-coated slides, were incubated overnight at 4°C with antibodies 285/298 and then processed as described above for Antisense primer 5Ј-CCATCCTCTCGAATTCGTCG-3Ј ϩ 515 63
Oligonucleotide Primers Used for the Identification of Transcripts by PCR
Positions of the primers are given for their 5Ј ends with regard to the ATG codon (ϩ1).
the cells. No difference was detected between fixed and unfixed samples. Specimens were examined with a Zeiss III light microscope equipped for epifluorescence. The specificity of the immunolabelings was checked by carrying out control experiments similar to those described above for the immunoblotting analyses.
Double-Labeling Experiments
Samples (young embryos; hearts dissected from embryos, newborns, and adults; and interventricular septa dissected from adult hearts) were embedded in Tissue-Tek OCT compound as above, after fixation or without fixation, and then frozen, and serial sectioned. The sections were incubated overnight at 4°C with the rabbit polyclonal antibodies 285/298 and then for 1 hour at room temperature with the anti-desmin or anti-Cx43 mouse monoclonal antibody. The sections were washed with PBS and then incubated for 1 hour with TRITC-labeled goat anti-rabbit IgGs (see above) or when mentioned with indocarbocyanine (Cy3)-conjugated donkey antirabbit F(abЈ) 2 fragments (Jackson ImmunoResearch Laboratories; dilution, 1:400), mixed with FITC-labeled sheep anti-mouse IgGs (Sigma Aldrich Chimie; dilution, 1:200). The sections were processed and analyzed as described above.
Frozen sections from fixed (see above) or unfixed mouse ovary were incubated overnight at 4°C with the rabbit antibodies 285/298 and then for 1 hour at room temperature with the anti-Cx43 mouse monoclonal antibody. The primary antibodies were revealed using a mixture of TRITC-labeled goat anti-rabbit IgGs and FITC-labeled sheep anti-mouse IgGs (see above). The sections were analyzed by confocal laser scanning (CLS) microscopy using a Zeiss LSM 410 system mounted on a Zeiss Axiovert microscope (model 135M). An argon laser and a HeNe laser, both equipped with attenuating filters, were used as excitation sources at 488 and 543 nm, respectively. The confocal system was equipped with filters and detectors designed for either the simultaneous or the separate recording of FITC and TRITC. The emitted images were digitized, and pictures from screen images were printed with an 8800 Sony video printer.
Immunoelectron Microscopy
Samples of mouse ovary were fixed as described 52 and embedded in LR Gold resin (TAAB Laboratories Equipment, Ltd). Ultrathin sections were incubated successively with antibodies 285/298 (5 g/mL) and 10-nm gold-labeled goat anti-rabbit IgGs (Aurion) diluted to 1:30. 53 Sections were examined with a Zeiss EM 912 electron microscope. Control experiments were similar to those carried out for immunoblotting analyses.
Results
Cx45 Gene Transcript Is Present in Heart From Early Developmental Stages (8.5 dpc) to the Adult Stage
In mouse, the heart starts to beat at 8.5 dpc. 42, 54 It is at this stage an S-shaped tube traversed by slow peristaltic contractions. This primitive cardiac activity, which has been well characterized in rat heart, 55 implies that the myocytes express 1 or more Cxs assembled into gap junction channels. To complete previous investigations on Cx43 and Cx40, 13 we have searched for Cx45 gene transcript in mouse heart from the first contraction stage to the adult stage.
RNA extracted from embryonic and fetal hearts (8.5, 9, 10, 11, 12, 14, 16, and 19 dpc), from young mouse heart (1 and 2 weeks postpartum), and from adult heart was reversed transcribed as indicated in Materials and Methods. The cDNAs generated by RT were amplified by PCR or nested PCR (8.5-dpc samples) with primer pairs unique for Cx45 (Table) , and the resulting amplicons were analyzed by electrophoresis. At all stages investigated, the amplicons were of the predicted size, 363 or 915 bp, for nested PCR or PCR experiments, respectively ( Figure 1A ). The identity of 915-bp amplicons was confirmed by enzymatic digestion with BglII and BamHI ( Figure 1B ) and by nested PCR (not shown). RNA extracted from 8.5-dpc samples was also shown to contain desmin gene transcript ( Figure 1A , lane 1), which confirmed the presence of differentiated myocytes in these samples. 57 Analyses of RT-PCR control experiments revealed no signal. The contamination of the analyzed samples with noncardiac cells had low probability, but it cannot be completely ruled out. These results indicate that Cx45 gene transcript was present in mouse heart as early as the beginning of cardiac activity and throughout development up until the adult stage. The next step was aimed at investigating by in situ hybridization the spatial distribution of this transcript and identifying the cardiac cells that expressed it. (2 g) extracted from mouse heart at different developmental stages were reverse transcribed as indicated in Materials and Methods. The cDNAs generated by RT were amplified by nested PCR (8.5-dpc samples) or PCR with primers unique for Cx45 (Table) . The predicted and measured sizes of Cx45 amplicons were of 363 and 915 bp for nested PCR (lane 2; 8.5 dpc) and PCR (even-numbered lanes 4 to 22), respectively. At all developmental stages, investigated RNA was demonstrated to contain desmin transcript, but only the desmin amplicon (229 bp) generated from 8.5-dpc samples is shown (lane 1). Note that the intensity of bands corresponding to the amplified GAPDH fragments (320 bp) indicates that similar amounts of RNA were used at all stages (odd-numbered 
Changes of Expression Pattern of Cx45 Gene Transcript During Heart Development, as Seen by In Situ Hybridization
The 8-to 8.5-dpc embryos hybridized with antisense Cx45 probe presented a strong and specific labeling of the ectoderm (Figure 2A and 2B), which substantially weakened at further developmental stages. At 8 dpc, the whole primitive heart appeared to be labeled with a stronger expression of the transcript in the inflow tract ( Figure 2B ). At 8.5 dpc, the transcript was detected in all of the cardiac compartments ( Figure 2C ), including again the inflow tract, and this expression pattern persisted until 10 dpc ( Figure 2D , 9 dpc; Figure 2E , 2G, and 2H, 10 dpc). At this stage the most remarkable labelings were those of the atrioventricular canal and the outflow tract ( Figures 2G, 2H, 3A , and 3D). The 11-dpc stage was characterized by a weakening of the labeling in the left ventricle, as was clearly visible in ventral views of the heart ( Figure 2I ), whereas the expression of the transcript was maintained in the other cardiac regions ( Figure  2J ). In the ventricles of 12-to 12.5-dpc hearts, the transcript was expressed, weakly and diffusely ( Figure 2K and 2L), whereas more distinct expression was always seen in the outflow tract ( Figure 2K ) and the anterior part of the right ventricle ( Figure 2L ). Weak labeling was sometimes observed in the atria at 12 dpc, but it was no longer detected by 12.5 dpc ( Figure 2L ). In previous experiments, 13 the detection of Cx40 transcript by whole-mount in situ hybridization in 9-to 11-dpc embryonic hearts had required 2-to 4-hour incubation times (4°C) with the chromogenic substrate. For the detection of Cx45 transcript, no labeling was seen for incubations shorter than 8 to 10 hours (4°C), which testifies to the low abundance of this transcript in heart.
Whole-mount hybridized embryos were serial sectioned, and the sections were examined to identify the cardiac cells expressing Cx45 transcript. In the heart, myocytes were seen to express the transcript, and this is illustrated in Figure 3 for the 10-dpc stage. In the thin atrial walls, all of the myocytes were equally labeled ( Figure 3A and 3B); in contrast, in the ventricular walls, an expression gradient was observed, extending from the outermost-layer myocytes forming a compact layer, which were distinctly labeled, to the trabecular myocytes, which were not labeled or were very weakly labeled ( Figure 3A and 3C) . The labeling of the atrioventricular canal observed in whole-mount embryos was confirmed by examination of sections ( Figure 3D ).
At developmental stages later than 12.5 dpc, the hybridization experiments were carried out on sections to avoid the problem of the penetration of the probe in the tissues. These experiments are illustrated in Figure 4 for the 14-, 16-, and 18-dpc stages. The expression of SERCA2 transcript was used to identify the myocardium 45 ( Figure 4B , 4D, and 4F). At the 3 developmental stages investigated, very weak and diffuse labeling was detected in the ventricles, with a slightly more distinct staining in the outflow tract myocardium ( Figure 4A and 4C) . Besides this labeling, the coronary vessels were also faintly positive in 18-dpc samples ( Figure  4E ), recalling the expression pattern of Cx40 transcript in the ventricular walls. 20 ,56
Immunodetection of Cx45 Protein in Mouse Heart Myocytes Depends on the Developmental Stages Investigated and the Cardiac Tissues Analyzed
The studies described above, dealing with the expression pattern of Cx45 gene transcript, were completed with investigations of the distribution of Cx45 protein at different developmental stages. The first step of these investigations was the characterization of antibodies specific for Cx45. This characterization is reported in the paragraph below.
In a first step, it was demonstrated, using ELISA assays, that the affinity-purified antibodies 285/298 specifically recognized both the immunogenic peptide YSAPPGYNIAVK-PDQ and its carboxyl-terminal domain NIAVKPDQ (not shown). In contrast, no affinity was detected between antibodies 285/298 and the amino-terminal domain (YSAPPGY) of the immunogenic peptide. In a second step, biological samples known to express Cx45 gene products abundantly or in low amounts, such as mouse ovary, SKHep1, HeLa, and UMR 106 cell lines, 24, 26, 40, 41, 57 Figure 5A ). These results were in agreement with those previously published, 24, 30, 40, 57 although the electrophoretic mobility of the detected protein (48 000) was slightly slower than that reported (45 000). This could be due to either the uncertainty of the M r measurements or the composition of the polyacrylamide gels used.
The specificity of antibodies 285/298 was further investigated by immunofluorescence. In some HeLa cell preparations, infrequent and dispersed tiny spots were observed between adjacent cells (not shown), as reported 29 ; in others, no labeling was observed. In contrast, in SKHep1 cells ( Figure 6C and 6D) and in UMR 106 cells (not shown), conspicuous immunoreactive sites were observed at the cell periphery, as expected for junctional labeling, and also, but to a lesser extent, inside the cells. In the ovaries, immunoreactivity was seen to be mainly associated with the granulosa cells ( Figure 6A and 6B) and partially colocalized with Cx43 (Figure 7) , as previously reported for anti-Cx45 antibodies. 57 No immunoreactive site was seen in the above samples subjected to the control experiments (not shown). In adult mouse heart, where, as in the ovaries, Cx43 is strongly expressed, the major part of the working myocardium was immunonegative to antibodies 285/298 ( Figure 10C through  10G) . The specificity of antibodies 285/298 was finally investigated by immunoelectron microscopy. In ovary sections treated for immunoelectron microscopy, numerous gap junctions, between the granulosa cells, were seen decorated with gold particles (Figure 8 ), whereas the intracellular organelles and the cytosol were free of labeling. No immu-noreactivity was detected in the sections prepared according to the control procedures (not shown).
The results described above demonstrate that antibodies 285/298 are specific for Cx45, and they will hereafter be referred to as anti-Cx45 antibodies. They were used in the experiments described below to investigate the expression and the distribution of Cx45 in mouse heart during its morphogenesis.
In the 8.5-dpc cardiac tube, the myocardium was identified by its immunoreactivity with anti-desmin antibodies. 58 It surrounded the endocardium, which was desmin negative ( Figure 9A and 9B) . At this stage the detection of Cx45 was homogeneous throughout the myocardium, and the periphery of the myocytes appeared to be more or less regularly labeled with anti-Cx45 antibodies ( Figure 9C and 9D) . At 9.5 dpc, the primitive atrium is separated from the common ventricular chamber by the atrioventricular canal ( Figure 9E ). A few immunoreactive sites were observed in the thin atrial wall, always associated with the outermost myocytes ( Figure 9E through 9G). Myocytes expressing Cx45 were also seen in the atrioventricular canal as shown in Figure 9H and 9I. In the ventricular wall, Cx45 was clearly detected, but its distribution was polymorphic. In some samples, most of the myo- No labeling is detected in these embryos. In contrast, embryos of the same stage (8 dpc) hybridized with the Cx45 antisense probe (B) present a general labeling of the ectoderm and of the heart (*). More intense labelings are observed in the inflow tract (arrowhead) and the neural folds (nf). A heart dissected from an 8.5-dpc hybridized embryo is shown in panel C. The primitive ventricle (v), which partially hides the primitive atrium (a), opens into the outflow tract (oft) extended by the aortic sac from which the arch 1 arteries (*) emerge. Note that all of the cardiac regions, including the outflow tract, are labeled. This expression pattern is found again in the heart of 9-dpc embryos. This is illustrated in panel D, which shows part of a 9-dpc embryo. The primitive atrium (a), the primitive ventricle (v), and the outflow tract (oft) are clearly identified in this ventral view of the heart. md indicates the (unlabeled) mandibular component of the first branchial arch. E and F, Lateral views of whole embryos at 10 and 11 dpc, respectively. Labeling of the ectoderm has substantially weakened compared with the previous developmental stages. The strongest expressions of Cx45 transcript are observed in the forebrain (fb), the heart, and the forelimb (fl) and hindlimb (hl) buds. Note also the labeling of the paired dorsal aortae (da). Hearts collected from 10-dpc hybridized embryos are shown in panels G (ventral view) and H (dorsal view). The left and right parts of the embryonic atrium (la and ra) and the left and right parts of the embryonic ventricle (lv and rv) are well differentiated. These regions of the myocardium as well as the outflow tract (oft) and the atrioventricular canal (H, *) express the Cx45 transcript. I and J, Ventral (I) and dorsal (J) views of a heart dissected from an 11-dpc hybridized embryo. Legends for these panels are the same as those for panels G and H. A significant weakening of the labeling is observed in the ventral side of the left embryonic ventricle (I, lv). Hearts (ventral views) from 12-and 12.5-dpc embryos are shown in panels K and L, respectively. Note the absence of labeling in the atria of these samples. Labeling observed in the ventricles was always weak and diffuse at these stages. In contrast, distinct expression of the transcript was usually detected in the outflow tract (K) or the anterior part of the right ventricle (L, *). cytes forming the compact ventricular layer were labeled ( Figure 9J through 9L) ; in others, only a few myocytes were seen to express Cx45. This latter pattern of expression was found again, in even more marked form, in the 10.5-dpc heart ventricular wall, where Cx45 was detected only in some rare myocytes (not shown). At this same stage, a strong labeling caused by anti-Cx45 antibodies was observed between the differentiating keratinocytes of the forelimb buds ( Figure  10A and 10B) , indicating that the loss of immunoreactivity described above was specific and endogenous to the myocardium. Beyond 11 dpc, and until the 7-day postpartum (dpp) stage, no significant immunofluorescence signal was detected in the atrial and ventricular free walls. This also held true at the adult stage for the major part of the working myocardium ( Figure 10C through 10G) , as reported. 29 However, in a small number of sections, Cx45 was detectable at high magnification, in trace amounts, in some small loci localized in the ventricles ( Figure 10H and 10I) . In addition, at this same stage, Cx45 was seen in low amounts in the anterior region of the interventricular septum ( Figure 10J through 10L) , associated with the common His bundle, as previously described. 29, 39 No attempt was made to investigate further the expression of Cx45 in the conduction system (but see References 29 and 39) . This would have been beyond the scope of the present work. The specificity of the labelings described above was checked at all stages investigated with appropriate control experiments (see Materials and Methods).
In preliminary experiments, several attempts were made by immunoblotting to check for the presence or the absence of Cx45 in the homogenates of hearts collected at the same developmental stages as those used for the immunofluorescence experiments. Because of the poorly reproducible results obtained for certain developmental stages, we finally focused the Western blot experiments on 3 stages: 9.5 dpc, 7 dpp, and the adult stage. The expression of Cx45 in early embryonic heart was confirmed: in 9.5-dpc heart homogenates, Cx45 was detected as a 48-kDa protein, in agreement with the above results, but it was found to be consistently associated with a 52-kDa polypeptide, whatever the amount of material analyzed ( Figure 5B, lanes e and f) . No protein was revealed in immunoreplicas of control experiments (not shown). The 52-kDa polypeptide, which was shown not to be a phosphorylated form of Cx45 (S. Alcoléa et al, unpublished results, 1998), might be derived from the 48-kDa protein by an as-yet-unidentified post-translational modification. Two proteins with M r s similar to those reported above were also detected in immunoprecipitates resulting from the treatment of cultured neonatal rat myocyte homogenates with anti-Cx45 antibodies (see, eg, Figures 6A and 8A in Reference 37). We observed no significant fluorescence signal in neonatal mouse heart sections treated with anti-Cx45 antibodies, but a 48-kDa protein was specifically detected in 7-dpp heart homogenates, associated or not with the 52-kDa polypeptide ( Figure 5B,  lanes g and h) . The detection of this polypeptide was indeed demonstrated to be dependent on the protein load ( Figure 5B,  lanes g and h) , which suggests a quantitative decrease of this molecular species during heart development. Finally, no significant signal was revealed in the immunoreplicas of adult heart homogenates probed with anti-Cx45 antibodies.
Discussion
Cx45 in Developing Mouse Heart
A combination of techniques was used to investigate the expression and the spatiotemporal regulation of Cx45 gene products in mouse heart during development. RT-PCR experiments have conclusively demonstrated, by the completion of previous partial results obtained by Northern blotting, 20 that the Cx45 gene transcript was present in mouse heart from the early stages of cardiac morphogenesis (8.5 dpc, stage of the first contractions) to the adult stage. The presence of this transcript in embryonic and fetal hearts was confirmed by in situ hybridization experiments. In addition, these experiments have demonstrated that (1) the transcript was equally expressed in all cardiac compartments, including the inflow and outflow tracts and the atrioventricular canal, at early stages of morphogenesis (8.5 to 10.5 dpc), and (2) the abundance of transcript, which is constitutively low compared with that of Cx40 and Cx43 (see also Reference 20) , was downregulated from 11 to 12 dpc onward. At subsequent developmental stages, it was detected in the ventricles only, in a diffuse way, but with a more distinct expression level in the outflow tract. Figure 2E and 2F for the expression of Cx45 transcript in the forelimb buds of embryos of similar age. Note in panel B the strong immunoreactivity of keratinocytes due to anti-Cx45 antibodies. Bar in Bϭ50 m (representative of panels A and B). C through I, Phase-contrast (C and H) and immunofluorescence (D through G and I) micrographs of adult mouse heart sections. Sections were treated with both anti-Cx43 and anti-Cx45 as described in Materials and Methods. Anti-Cx45 antibodies were revealed with Cy3-conjugated donkey anti-rabbit F(abЈ) 2 fragments. Cx43 is abundantly expressed in heart (as illustrated in panels C and D for the ventricular tissue), in contrast to Cx45, which is not detected in the major part of the working myocardium (panels C and E, low magnification; panels F and G, high magnification). However, in some small foci, Cx45 is detectable at high magnification in trace amounts (panels H and I). Bar in Eϭ100 m (representative of panels C and D); bar in Iϭ50 m (representative of panels F, G, and H). J through L, Phase-contrast (J and K) and immunofluorescence (L) micrographs of a section in adult mouse heart interventricular septum. In panel J, the top of the septum is in the right upper corner. Panels K and L are enlargements of the box in panel J. The section was treated with anti-Cx45 antibodies revealed with Cy3-conjugated donkey anti-rabbit F(abЈ) 2 fragments. Sister sections were incubated with anti-Cx40 antibodies to identify the conduction system (not shown). 10 Examination of sections from whole-mount in situ hybridized embryos has shown that the Cx45 transcript was associated with myocytes. In addition, the expression of Cx45 protein in the myocytes of young embryonic hearts (8.5 to 9.5 dpc) was demonstrated by its immunodetection by fluorescence microscopy. Surprisingly, beyond 10.5 dpc (with the exception of the adult heart, which will be discussed later), Cx45 protein was no longer detected by conventional immunofluorescence microscopy in the embryonic, fetal, or neonatal working myocardium, even though the transcript was present in heart at these developmental stages (as demonstrated by RT-PCR and in situ hybridization experiments), Figure 11 . Molecular bases for the propagation of electrical activity in the embryonic mouse heart. Three Cxs have been demonstrated to be associated with the myocytes, Cx40, Cx43, and Cx45, the expression patterns of which, complementary or partially redundant, should account for the propagation of electrical activity in the embryonic myocardium. The diagrams in this figure illustrate the expression patterns of Cx43 (green), Cx40 (magenta), and Cx45 (blue) gene products at the first stages of cardiac morphogenesis. The heart is schematized as a series of independent compartments that are along the caudorostral axis, as follows: the inflow tract (ift), where the sinoatrial node (ie, the pacemaker) is localized; the atrial compartment (a); the atrioventricular canal (avc); the ventricular compartment (v); and the outflow tract (oft). In the embryonic ventricles, the scalloped region represents the trabecular component of this compartment. Trabeculae differentiate at Ϸ9.5 dpc. Blood circulation in the heart is indicated by red arrows. Developmental stages illustrated in the figure are specified at the top of each diagram (E 8.5ϭ8.5 dpc, E 9.5ϭ9.5 dpc, etc). Note that the stages represented change according to the expression pattern of the Cx considered. During heart morphogenesis, the Cx43 gene activation, which is evidenced by the detection of both the transcript and the protein by in situ hybridization and immunofluorescence microscopy, respectively, occurs from 10.5 dpc according to a rostrocaudal gradient, which involves first the embryonic ventricle and then the atrium. 13 The expression of Cx43 is stronger in the trabecular component (dark green) than in the outermost-layer myocytes of the ventricular component (light green). The Cx40 gene activation occurs earlier, at 9.5 dpc, according to a caudorostral gradient, which involves first the atrial compartment and then successively the left and right embryonic ventricles. 13 As for Cx43, the expression of Cx40 is stronger in the trabeculae (dark magenta) than in the outermost ventricular myocytes (light magenta). Bottom panel (Cx45) represents the expression pattern of the Cx45 gene transcript from 8.5 to 12.5 dpc. The abundance of this transcript in the heart is constitutively much lower than those of the transcripts from Cx43 and Cx40 genes (this study and Reference 20) . At the stage of the first contractions (8.5 dpc), the Cx45 gene transcript is detected, in contrast to Cx43 and Cx40 gene products, in all cardiac compartments including the inflow and outflow tracts and the atrioventricular canal. This expression pattern persists until the 10-dpc stage (not shown) with an expression weaker in the trabeculae than in the outermost layer myocytes. From 11 dpc, a progressive downregulation occurs that proceeds along the caudorostral axis. The Cx45 gene transcript is shown to be expressed in the sinoatrial node at 8.5 dpc, although it has not been precisely detected in this specialized region. However, the heart needs a functional pacemaker, and, given that Cx45 is so far the only Cx demonstrated to be expressed in the 8.5-dpc heart, it has been predicted that this Cx could couple the nodal cells.
and the protein was detected in Western blots of 7-dpp heart homogenates. The discrepancy between these results is perhaps only apparent, and the following hypothesis might provide the explanation. In early stages of cardiac morphogenesis (8.5 to 9.5 dpc), Cx45 is sufficiently concentrated in the plasma membrane of myocytes to be immunodetected by fluorescence microscopy. At later developmental stages, subsequent to the downregulation of the transcript, the synthesis of Cx45 decreases and its concentration in the membrane of ventricular myocytes is below the detection limit of the fluorescence microscope. One might postulate that the low number of Cx45 molecules present in the membrane could be aggregated into immunofluorescence-detectable gap junctions, but this is apparently not the case, because the channels they form probably remain dispersed in the membrane. The expression of Cx45 in HeLa cells is a similar example that supports the above hypothesis. Although no gap junction plaques have been observed in wild-type HeLa cell plasma membranes, 41 high-resolution electrophysiological measurements, 23 Western blotting ( Figure 5A ), and immunogold labeling of freeze-fractured membrane 41 have demonstrated that Cx45 channels were present, albeit in very low amounts, in wild-type HeLa cells. Nevertheless, the immunodetection of these channels by fluorescence microscopy remains elusive. Immunoreactivity, when detected (References 29 and 30 and this study), is only seen as infrequent and tiny spots between adjacent cells, probably because most of the Cx45 channels are not aggregated into gap junction plaques but dispersed in the plasma membrane, as has been recently demonstrated. 41 The elegant technique of freeze-fracture immunogold labeling, associated with the double-patch clamp technique on freshly dissociated embryonic myocyte pairs, should go some way toward confirming the above hypothesis. This hypothesis, which accounts for our results on the working myocardium, does not exclude the possibility that Cx45 might be sufficiently expressed to be immunodetected in some specialized regions of the heart. It is indeed the case in the conduction system of adult and fetal mouse heart, as recently demonstrated. 29, 39 Strangely enough, the intensity of signal we have detected on sections by in situ hybridization in the fetal conduction system was as low as that seen in the working myocardium. This may suggest a differential regulation of Cx45 expression according to the cardiac tissue in which this Cx is synthesized.
Cx45 was undetectable in the major part of adult mouse heart. It was, however, clearly seen in the anterior regions of the interventricular septum and in trace amounts in some small foci dispersed in the ventricular free walls. Although this remains to be demonstrated, one might speculate that these immunopositive foci contain terminal elements of the conduction system (ie, Purkinje fibers). In a general way, expression of Cx45 in adult heart is extremely low, as indicated by the failure to detect it by immunoblotting in adult heart homogenates (Reference 29 and this study). This would appear to reflect the general downregulation of Cx45 gene products, which starts quite early during cardiac morphogenesis. The results we have described are, in addition, in complete disagreement with those reported for dog and human heart, in which Cx45 was shown to be expressed, fairly strongly, in all cardiac tissues. 27, 28, [33] [34] [35] [36] Species difference, or the characteristics of the antibodies used, might account for this discrepancy.
The myocytes have been demonstrated to synthesize Cx45, but other cardiac cells are probably also capable of expressing it. Clues are given in Figures 2E and 4E in which the paired dorsal aortae and coronary vessels, respectively, are shown to express Cx45 gene transcript. In addition, faint and specific immunolabeling was detected very infrequently in coronary vessels of adult mouse heart (not shown). These observations indicate that vessels, including coronary vessels, can express Cx45. This is remarkably well illustrated by the strong expression of Cx45 in the smooth muscle layers of pig heart coronary vessels (D. Gros et al, unpublished results, 1998).
Cx45, Cx of the Primitive Heart
At the stage of the first contractions (8.5 dpc), the Cx40 and Cx43 gene transcripts have been demonstrated to be present in heart, as is confirmed by the results of RT-PCR experiments, 13 but at this same stage Cx40 and Cx43 proteins have not been detected. They are detected successively in the embryonic ventricle at 9.5 dpc for Cx40 and then in the atrium at 10.5 dpc for Cx43 13 ( Figure 11 ). How then is the electrical activity propagated from the pacemaker, located in the inflow tract, to the primitive ventricle at the stage of the first contractions? Clearly, Cx45 channels play a role as early as this stage in the conduction phenomenon. The Cx45 gene transcript was shown to be expressed in the heart before the first contractions, at 8 dpc; this transcript and the Cx45 protein were both detected in the 8.5-dpc heart. The coordination of the myocytes during the slow peristaltic contractions that occur at this stage would then be controlled by the low unitary conductance of Cx45 channels. Cx45 could thus be termed the "primitive cardiac Cx," because it is, so far, the only Cx expressed in the primitive tubular heart.
The expression of Cx40 and Cx43 in the early embryonic heart only concerns the ventricular and atrial tissues ( Figure  11 ). At no developmental stages were these Cxs shown to be associated with the myocytes of the inflow and outflow tracts or the atrioventricular canal. 12, 13 Remarkably, the Cx45 gene was demonstrated to be expressed in those compartments that are characterized by slow impulse conduction. 59 The downregulation of Cx45 that occurs in embryonic heart is counterbalanced by the spatiotemporal upregulation of both Cx40 and Cx43. This is illustrated in Figure 11 , which clearly shows the complementary expression, sometimes partially redundant, of the 3 Cxs associated with the myocytes in the embryonic heart. Cx43 was shown to be involved in the development of the right ventricle and the impulse conduction in the ventricular walls. 16 -19 Cx40 was demonstrated to be essential for the rapid conduction of impulse in the His-Purkinje system. 21, 22 The analysis of heart from Cx45 null mice should confirm, or invalidate, the primordial role that Cx45 should play in the development and the physiology of this organ given the unique characteristics of its expression.
